Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin
- 4 July 2003
- Vol. 21 (23) , 3335-3341
- https://doi.org/10.1016/s0264-410x(03)00038-0
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Coimmunization with IFN- gamma or IL-2, but Not IL-13 or IL-4 cDNA Can Enhance Th1-Type DNA Vaccine-InducedJournal of Interferon & Cytokine Research, 2000
- A novel concept in mucosal adjuvanticity: The CTA1‐DD adjuvant is a B cell‐targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunitImmunology & Cell Biology, 1998
- Induction of Mucosal and Systemic Responses against Human Immunodeficiency Virus Type 1 Glycoprotein 120 in Mice after Oral Immunization with a Single Dose of aSalmonella-HIV VectorAIDS Research and Human Retroviruses, 1997
- Codon usage limitation in the expression of HIV-1 envelope glycoproteinCurrent Biology, 1996
- Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal MuscleHuman Gene Therapy, 1993
- Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.Journal of Clinical Investigation, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1.The Journal of Experimental Medicine, 1985
- Size and Structure of the Cholera Toxin Molecule and Its SubunitsThe Journal of Infectious Diseases, 1976